Literature DB >> 20532704

Clinical trial report: eradication of Helicobacter pylori and MALT Lymphoma: where do we stand?

Walter J Coyle1.   

Abstract

Entities:  

Year:  2010        PMID： 20532704     DOI： 10.1007/s11894-010-0118-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  4 in total

1.  The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication.

Authors:  Lara M N El-Zahabi; Faek R Jamali; Ihab I El-Hajj; Mohammed Naja; Ziad Salem; Ali Shamseddine; Nagi S El-Saghir; Ghazi Zaatari; Fady Geara; Assaad M Soweid
Journal:  Gastrointest Endosc       Date:  2007-01       Impact factor: 9.427

Review 2.  Diagnosis and staging in gastrointestinal lymphoma.

Authors:  Henk Boot
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-02       Impact factor: 3.043

3.  t(11;18)(q21;q21) is the most common translocation in MALT lymphomas.

Authors:  I A Auer; R D Gascoyne; J M Connors; F E Cotter; T C Greiner; W G Sanger; D E Horsman
Journal:  Ann Oncol       Date:  1997-10       Impact factor: 32.976

4.  Comparative expressed sequence hybridization studies of t(11;18)(q21;q21)-positive and -negative gastric MALT lymphomas reveal both unique and overlapping gene programs.

Authors:  Xavier Sagaert; Thomas Tousseyn; Vera Vanhentenrijk; Peter Van Loo; Mathijs Baens; Peter Marynen; Gert De Hertogh; Karel Geboes; Christiane De Wolf-Peeters
Journal:  Mod Pathol       Date:  2010-01-15       Impact factor: 7.842
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.